Pro-Pharmaceuticals, Inc.
189 Wells Avenue
Suite 200
Newton
Massachusetts
02459
United States
Tel: 617-559-0033
Fax: 617-928-3450
Website: http://www.pro-pharmaceuticals.com/
176 articles about Pro-Pharmaceuticals, Inc.
-
Pro-Pharmaceuticals, Inc. to Hold Conference Call to Provide Update Following Company’s Annual Meeting of Stockholders
5/26/2011
-
Pro-Pharmaceuticals, Inc. Changes Company Name to Galectin Therapeutics
5/26/2011
-
Pro-Pharmaceuticals, Inc. to Hold Conference Call to Provide Update Following Company’s Annual Meeting of Stockholders
5/20/2011
-
Pro-Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
5/13/2011
-
Pro-Pharmaceuticals, Inc.' Presentation at Noble Financial Capital Markets' Seventh Annual Equity Conference to Be Webcast Live
5/10/2011
-
Pro-Pharmaceuticals, Inc. Selects SAFC to Ramp-up the Manufacture of DAVANAT(R) for Anticipated Use in Clinical Trials & Sales in Colombia
5/3/2011
-
Pro-Pharmaceuticals, Inc. Expands Patent Coverage to Japan
4/25/2011
-
Ludwig Institute For Cancer Research (LICR) and Pro-Pharmaceuticals, Inc. Discover That DAVANAT(R) Enhances the Ability of Anti-Tumor T Lymphocytes to Kill Tumor Cells
4/20/2011
-
Pro-Pharmaceuticals, Inc. Expands Patent Portfolio with New Patents in the U.S. and Australia
3/22/2011
-
Pro-Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter 2010 Financial Results
3/15/2011
-
Pro-Pharmaceuticals, Inc. Names Peter G. Traber, M.D., President & Chief Executive Officer
3/9/2011
-
Pro-Pharmaceuticals, Inc. Receives Final Tranche of Funding from Federal Grant; Raises Cash Position to $8 Million
2/10/2011
-
Pro-Pharmaceuticals, Inc. to Present Corporate Update at Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/8/2011
-
Pro-Pharmaceuticals, Inc. Closes $2.1 Million Offering
1/6/2011
-
Pro-Pharmaceuticals, Inc. to Present Corporate Update at San Francisco Biotech Conference
1/4/2011
-
Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Maintains Target Price of $2.10
12/27/2010
-
Pro-Pharmaceuticals, Inc. & Mount Sinai School of Medicine Announce New Liver Fibrosis Research Collaboration
12/21/2010
-
Pro-Pharmaceuticals, Inc. Expands Patent Coverage to Australia
12/7/2010
-
Pro-Pharmaceuticals, Inc. Reports Third Quarter 2010 and Nine Months Financial Results
11/12/2010
-
Pro-Pharmaceuticals, Inc. to Receive $489,000 in Federal Grants for Its Galectin-Targeting Cancer and Liver Fibrosis Compounds
11/2/2010